DSIP Peptide At a Glance Why People Are Talking About DSIP for Opioid Dependence When someone comes off opioids, a few things tend to hit hard: Severe insomnia Anxiety and restlessness Dysregulated stress response Physical discomfort DSIP gets attention because its believed to: Promote deeper, more restorative sleep Help regulate stress hormones Potentially reduce withdrawal-related discomfort Some early research has explored DSIPs effects on withdrawal symptoms, including in opioid-related contexts
Beneficial health effects of Menaquinone-7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients
L-arginine in intestinal ischemia animal models aids mucosal healing by reducing tissue damage (Fotiadis et al., 2016), and a similar protective effect of L-arginine was also reported in LPS (bacteria-derived lipopolysaccharide)-challenged weaned pigs (Zhu et al., 2013)
In light of this potential significant safety issue, the development of Lotiglipron has been discontinued, meaning the drug did not progress to further clinical trial stages to evaluate its efficacy and safety
MicroRNA and mRNA transcriptome profiling in primary human astrocytes infected with Borrelia burgdorferi
BPC-157 stimulates angiogenesis via the VEGF (Vascular Endothelial Growth Factor) and eNOS (endothelial nitric oxide synthase) pathways, increasing NO production, which promotes vasodilation and the formation of new capillaries